Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acne Infection01:27

Acne Infection

43
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
43
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

554
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
554
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

290
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
290
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

446
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
446
Epistaxis01:30

Epistaxis

714
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
714

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Low-dose isotretinoin for difficult-to-treat rosacea: Enough evidence to be convinced-What's next?

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

You wait ages, and then two arrive at once: reporting guidelines should not be like buses.

Journal of clinical epidemiology·2025
Same author

Developing reporting checklist items from systematic review findings: a roadmap and lessons to be learned from ACCORD.

Journal of clinical epidemiology·2024
Same author

Tuning up the chords of consensus research with the ACcurate COnsensus Reporting Document (ACCORD).

The British journal of dermatology·2024
Same author

ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: Guidance and examples to support reporting consensus methods.

PLoS medicine·2024
Same author

Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.

JAMA dermatology·2024
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
関連記事をすべて見る

関連する実験動画

Updated: Mar 29, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

908

ロザケアに対する介入

Esther J van Zuuren1, Zbys Fedorowicz2

  • 1Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.

JAMA
|December 10, 2015
PubMed
まとめ
この要約は機械生成です。

効果的なロザセア治療には,局所用ブリモニジン,アゼラ酸,イヴァルメクチン,および経口ドキシサイクリンおよびイソトレチノインが含まれます. ほとんどの治療法はプラセボと同様の有害事象の発生率を示し,ロザセアの管理のための良好な安全性プロファイルを示しています.

さらに関連する動画

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K

関連する実験動画

Last Updated: Mar 29, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

908
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.8K

科学分野:

  • 皮膚科
  • 薬理学について
  • クリニカル・セラピー

背景:

  • 顔の外見に影響する慢性炎症性皮膚疾患です.
  • 効果的な安全な治療法を特定することは 患者の管理に極めて重要です

研究 の 目的:

  • ロザセアに対する様々な介入の有効性と安全性を評価する.
  • 治療結果と有害事象プロフィールを比較する.

主な方法:

  • 臨床試験の体系的レビューとメタ解析
  • 異なる治療クラスに対する証拠の質の評価

主要な成果:

  • 局所用ブリモニジン,アゼラ酸,イヴァルメクチン,経口ドキシサイクリン,およびイソトレチノインが ローザセアの改善を裏付ける高品質の証拠があります.
  • 局所用メトロニダゾール,経口用テトラサイクリン,レーザー/光療法,局所用サイクロスポリン (眼性赤毛症) については質の低い証拠がある.
  • ほとんどの介入では,プラセボと比較して有害事象の発生率が比較可能であった.

結論:

  • 局所療法と口服療法は,ロザセアに顕著な改善をもたらします.
  • 確立された治療法は一般的に好ましい安全性プロファイルを持っています.
  • さらに研究が進められれば,他の方法,特に眼性赤毛症の証拠が強化されるかもしれません.